KR950704002A - 모티프를 사용한 삼중 나선 복합체의 형성(formation of triple helix complexes using a novel motif) - Google Patents

모티프를 사용한 삼중 나선 복합체의 형성(formation of triple helix complexes using a novel motif) Download PDF

Info

Publication number
KR950704002A
KR950704002A KR1019950702400A KR19950702400A KR950704002A KR 950704002 A KR950704002 A KR 950704002A KR 1019950702400 A KR1019950702400 A KR 1019950702400A KR 19950702400 A KR19950702400 A KR 19950702400A KR 950704002 A KR950704002 A KR 950704002A
Authority
KR
South Korea
Prior art keywords
strand
target sequence
oligomer
strands
triple helix
Prior art date
Application number
KR1019950702400A
Other languages
English (en)
Korean (ko)
Inventor
죤 아놀드 쥬니어 라일
앨런 레이놀즈 마크
Original Assignee
라이오넬 엔. 사이몬
젠타 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라이오넬 엔. 사이몬, 젠타 인코포레이티드 filed Critical 라이오넬 엔. 사이몬
Publication of KR950704002A publication Critical patent/KR950704002A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6839—Triple helix formation or other higher order conformations in hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C12N2310/152—Nucleic acids forming more than 2 strands, e.g. TFOs on a single-stranded target, e.g. fold-back TFOs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
    • C12N2310/3521—Methyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019950702400A 1992-12-08 1993-12-08 모티프를 사용한 삼중 나선 복합체의 형성(formation of triple helix complexes using a novel motif) KR950704002A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98774692A 1992-12-08 1992-12-08
US07/987746 1992-12-08
PCT/US1993/011986 WO1994013326A1 (fr) 1992-12-08 1993-12-08 Formation de complexes a helice triple a l'aide d'un nouveau motif

Publications (1)

Publication Number Publication Date
KR950704002A true KR950704002A (ko) 1995-11-17

Family

ID=25533520

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950702400A KR950704002A (ko) 1992-12-08 1993-12-08 모티프를 사용한 삼중 나선 복합체의 형성(formation of triple helix complexes using a novel motif)

Country Status (8)

Country Link
EP (1) EP0673260A4 (fr)
JP (1) JPH08504103A (fr)
KR (1) KR950704002A (fr)
AU (1) AU684774B2 (fr)
CA (1) CA2151263A1 (fr)
IL (1) IL107934A0 (fr)
NZ (1) NZ259223A (fr)
WO (1) WO1994013326A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441130B1 (en) 1991-05-24 2002-08-27 Isis Pharmaceuticals, Inc. Linked peptide nucleic acids
US6451968B1 (en) 1991-05-24 2002-09-17 Isis Pharmaceuticals, Inc. Peptide nucleic acids
WO1994018835A1 (fr) * 1993-02-19 1994-09-01 Genta Incorporated Traitement de la calvitie associee aux androgenes au moyen d'oligomeres antisens
DE19842527A1 (de) * 1998-09-18 2000-03-23 Friedrich Schiller Uni Jena Bu Verfahren zur Bildung tripelhelixbildender Oligomere und deren Verbindungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2006008C (fr) * 1988-12-20 2000-02-15 Donald J. Kessler Methode pour obtenir des oligonucleotides synthetiques qui se lient specifiquement a des sites cibles sur des molecules d'adn double brin, en formant un triplex colineaire; methode d'utilisation de ces oligonucleotides synthetiques
US5176996A (en) * 1988-12-20 1993-01-05 Baylor College Of Medicine Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
US5399676A (en) * 1989-10-23 1995-03-21 Gilead Sciences Oligonucleotides with inverted polarity
HUT66828A (en) * 1991-03-27 1995-01-30 Res Corp Technologies Inc Single-stranded circular oligonucleotides

Also Published As

Publication number Publication date
AU684774B2 (en) 1998-01-08
NZ259223A (en) 1997-10-24
WO1994013326A1 (fr) 1994-06-23
AU6654094A (en) 1994-07-04
JPH08504103A (ja) 1996-05-07
IL107934A0 (en) 1994-04-12
EP0673260A1 (fr) 1995-09-27
EP0673260A4 (fr) 1999-04-14
CA2151263A1 (fr) 1994-06-23

Similar Documents

Publication Publication Date Title
Freemont et al. Cocrystal structure of an editing complex of Klenow fragment with DNA.
de Murcia et al. Poly (ADP-ribose) polymerase
Krasnow et al. Site-specific relaxation and recombination by the Tn3 resolvase: recognition of the DNA path between oriented res sites
Muniyappa et al. Mechanism of the concerted action of recA protein and helix-destabilizing proteins in homologous recombination.
Lu et al. Capacity of RecA protein to bind preferentially to UV lesions and inhibit the editing subunit (epsilon) of DNA polymerase III: a possible mechanism for SOS-induced targeted mutagenesis.
Grady et al. Highly conserved repetitive DNA sequences are present at human centromeres.
Lamothe et al. Accessory proteins for DNA polymerase alpha activity with single-strand DNA templates.
ATE470712T1 (de) Nukleinsäureliganden mit hoher affinität zu dem c5-protein des komplementsystems
JP3892450B2 (ja) バックグランドノイズの減少を伴う液相核酸サンドイッチアッセイ
FORTKAMP et al. Cloning and expression in Escherichia coli of a synthetic DNA for hirudin, the blood coagulation inhibitor in the leech
Bahl et al. Minimal length of the lactose operator sequence for the specific recognition by the lactose repressor.
AU3728897A (en) Methods for detecting and amplifying nucleic acid sequences using modified oligonucleotides having increased target specific Tm
WO1999049082A3 (fr) Nucleotides modifies et methodes utiles pour le sequençage d'acides nucleiques
ATE239090T1 (de) Methode zum generieren von einzelsträngigen dna molekülen
ATE225369T1 (de) Doppelsträngige peptidenukleinsäuren
RU95110871A (ru) Способы определения нуклеотидной последовательности
Chou et al. Sheared purine· purine pairing in biology
Henderson et al. Telomere G-strand structure and function analyzed by chemical protection, base analog substitution, and utilization by telomerase in vitro
Werel et al. Flexibility of the DNA enhances promoter affinity of Escherichia coli RNA polymerase.
Raghuraman et al. Oxytricha telomeric nucleoprotein complexes reconstituted with synthetic DNA
Acevedo et al. The coherence of synthetic telomeres
Sheflin et al. Mung bean nuclease cleavage of a dA+ dT-rich sequence or an inverted repeat sequence in supercoiled PM2 DNA depends on ionic environment
KR950704002A (ko) 모티프를 사용한 삼중 나선 복합체의 형성(formation of triple helix complexes using a novel motif)
Keller et al. Enhanced bleomycin-mediated damage of DNA opposite charged nicks. A model for bleomycin-directed double strand scission of DNA.
Kamau et al. Surface salt bridges modulate the DNA site size of bacterial histone-like HU proteins

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid